Case Study: BlairBlair is a 22-year-old transgender female. As part of the medical treatments for transitioning, she is currently taking 17-beta estradiol and spironolactone (blocks androgen receptors...

1 answer below »

Case Study: Blair

Blair is a 22-year-old transgender female. As part of the medical treatments for transitioning, she is currently taking 17-beta estradiol and spironolactone (blocks androgen receptors and alters testosterone production). Blair has come to see her GP today as she has had several episodes where she felt faint, and “may even have passed out on a couple of occasions”. It is some time since Blair attended the clinic, and you note when weighing her that she has lost a significant amount of weight and does not present as the active person you remember.

Blair mentions she doesn’t cook much and relies on the takeaway shop around the corner for most food these days.

Physical examination:

Height Weight Appearance

Temperature Blood Group

HR

BP

Respiratory rate Diet

Past patient history Social status

Urinalysis

Blood Bilirubin Urobilinogen

Ketone

Protein

Nitrite

Glucose

pH

Specific Gravity Leucocytes

178 cm

65 kg

Clean, dry skin, thin, significant muscle wastage

37.6◦C

AB+

80 bpm

105/66 mm Hg

22 bpm

Low fibre, high fat

History of depression

Living alone, lonely, lately has occasional sexual contact

-

-

0.1 mg/dL +

-

-

-

6.0 1.005 +


©ACU 2022

1





All topics and their key points listed below must be discussed in your essay

Topic 1: Reproduction (10 marks total)

Prostate tissue contains glandular structures relevant to Blair’s reproductive function. Explain the role of this glandular tissue in reproductive function, including any likely changes from normal in the secretion and resultant effects that are specific to Blair’s transition and the associated treatment. (4 marks)

Considering Blair’s current circumstances, describe the role of testosterone prior to the commencement of estradiol and spironolactone therapy and explain whether you expect her testosterone levels to be different to normal because of the therapy. Your discussion should include the homeostatic regulation of male reproductive physiology and the relevant, glands, cells, and hormones. (6 marks)

Topic 2: Cardiovascular system (5 marks total)

Consider Blair’s blood pressure result and discuss whether the mean arterial pressure is likely to be varied from normal. Blair has mentioned she sometimes feels ‘light-headed’ when standing quickly. Explain the role of baroreceptors in this situation. (5 marks)

Topic 3: Digestion/metabolism (8 marks total)

The night after consuming more carbohydrate in the one meal than the last month combined, Blair has abdominal cramps, flatulence, and diarrhea and quickly needs to find a toilet. Link these symptoms to undigested carbohydrate and explain the defecation reflex. (4.5 marks)

State the hormone that would have been MOST active in maintaining Blair’s blood glucose levels after her carbohydrate loaded dinner. Explain your answer. (3.5 marks)

Topic 4: Pharmacology (7 marks total)

Blair is taking spironolactone (which is considered a prodrug) tablets for androgen blocking as part of hormone replacement therapy.

Discuss the route of administration of spironolactone, and its likely bioavailability. Justify your response by explaining how bioavailability is impacted by hepatic first pass metabolism, and whether first pass metabolism is beneficial or detrimental to the function of spironolactone within the body. (4 marks)

Discuss the effect of spironolactone on elimination of other drugs. In your answer, you will need to relate back to the case study and clinical results for Blair. (3 marks)

Answered Same DayOct 30, 2022

Answer To: Case Study: BlairBlair is a 22-year-old transgender female. As part of the medical treatments for...

Dr. Sulabh answered on Oct 31 2022
39 Votes
BLAIR CASE STUDY 6
Name of the Student
Name of the College or University
Name of the Course
Date
Assignment
1:
Blair is a transgender female
patient who is prescribed spironolactone medicine for blocking the secretion of the testosterone hormone along with the intake of 17-beta estradiol as a treatment therapy option. The prostate gland is present in the pelvic cavity of males. This gland is considered to be a male reproductive organ. In this case study, the patient is feeling like she is fainting after receiving female hormone therapy. The prostate gland secretes an alkaline fluid that maintains the viability of the sperm inside the vagina during sexual contact. The contraction of the muscles surrounding the prostate gland causes the release of semen during the process of ejaculation (Public Health, 1988). During the transition from male to female, the levels of testosterone will decrease in this patient and the alkaline secretion from the prostate gland will also decrease. Further, there is a secretion of the prostate-specific antigen from the prostate gland which is involved in decreasing the density and thickness of the semen. In addition, there is a conversion of the testosterone hormone to another metabolite named dihydrotestosterone inside the prostate gland cells. There is not much correlation in the levels of testosterone after the estradiol therapy (Leinung et al., 2018).
There is a homeostatic feedback loop of the secretion of testosterone from the Leydig cells in the testis. Spironolactone therapy given to this patient is important as this medicine blocks the secretion of testosterone thus reducing the development of the male secondary characteristics in this patient. The hypothalamus in the brain gets stimulated to release the gonadotropin-releasing hormone which activates the anterior pituitary gland to secrete the luteinizing hormone. The Leydig cells get stimulated to release testosterone which activates the secondary sexual characteristics. Further, the negative feedback loop causes the inhibition of the secretion of the luteinizing hormone from the anterior pituitary gland. One more loop causes the release of the follicle-stimulating hormone from the anterior pituitary gland which activates the Sertoli cells leading to the process of spermatogenesis (nd, 2018).
References
1. Institute for Quality and Efficiency in Health Care. (2016, August 23). How does the prostate work? Nih.gov; Institute for Quality and Efficiency in Health Care (IQWiG)....
SOLUTION.PDF

Answer To This Question Is Available To Download

Related Questions & Answers

More Questions »

Submit New Assignment

Copy and Paste Your Assignment Here